Bronchitol poor sales still a major thorn imo
Operational savings but at what cost to revenue and the milestone of cashflow positive
Choice of Distributors and perhaps market research failing badly imo
Or Covid having major effect! even more so than expected
anyone do some research into that scar treatment ‘competition’ which they would be happy to share
- Forums
- ASX - By Stock
- SNT
- Ann: Investor presentation
Ann: Investor presentation, page-11
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.1¢ |
Change
-0.002(6.06%) |
Mkt cap ! $37.01M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.1¢ | $94.1K | 2.963M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31544 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 300000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31544 | 0.031 |
5 | 861333 | 0.030 |
9 | 1655681 | 0.029 |
8 | 2407142 | 0.028 |
3 | 787000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 300000 | 1 |
0.036 | 243902 | 1 |
0.040 | 400000 | 1 |
0.041 | 14300 | 1 |
0.043 | 5769 | 1 |
Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |